These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 33822057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC, Yarali H, Vuong LN, Carvalho JF, Özbek İY, Polat M, Le HL, Pham TD, Ho TM, Humaidan P, Alviggi C.
    Hum Reprod; 2021 Jul 19; 36(8):2157-2169. PubMed ID: 34179973
    [Abstract] [Full Text] [Related]

  • 3. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA, Eijkemans MJC, van Tilborg TC, Oudshoorn SC, van Golde RJT, Hoek A, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, Kuchenbecker WKH, Laven JSE, Mol BWJ, Torrance HL, Broekmans FJM, OPTIMIST study group.
    Hum Reprod; 2019 Jun 04; 34(6):1030-1041. PubMed ID: 31125412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N, Abdennebi I, Porcu-Buisson G, Chevalier N, Descat E, Piétin-Vialle C, Goro S, Brussieux M, Pinto M, Pasquier M, Bry-Gauillard H.
    Hum Reprod; 2023 May 02; 38(5):927-937. PubMed ID: 36864699
    [Abstract] [Full Text] [Related]

  • 6. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC, Oudshoorn SC, Eijkemans MJC, Mochtar MH, van Golde RJT, Hoek A, Kuchenbecker WKH, Fleischer K, de Bruin JP, Groen H, van Wely M, Lambalk CB, Laven JSE, Mol BWJ, Broekmans FJM, Torrance HL, OPTIMIST study group.
    Hum Reprod; 2017 Dec 01; 32(12):2485-2495. PubMed ID: 29121350
    [Abstract] [Full Text] [Related]

  • 7. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O, Eijkemans MJ, Lentjes EW, Torrance HL, Macklon NS, Fauser BC, Broekmans FJ.
    Hum Reprod; 2015 Jan 01; 30(1):170-8. PubMed ID: 25355590
    [Abstract] [Full Text] [Related]

  • 8. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P, Vuong TNL, Ho NAV, Vaiarelli A, Ho MT, Blockeel C, Camus M, Lam AT, van de Vijver A, Humaidan P, Tournaye H, Polyzos NP.
    Hum Reprod; 2017 Nov 01; 32(11):2225-2233. PubMed ID: 29040589
    [Abstract] [Full Text] [Related]

  • 9. In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial.
    Vuong LN, Ho VNA, Ho TM, Dang VQ, Phung TH, Giang NH, Le AH, Pham TD, Wang R, Smitz J, Gilchrist RB, Norman RJ, Mol BW.
    Hum Reprod; 2020 Nov 01; 35(11):2537-2547. PubMed ID: 32974672
    [Abstract] [Full Text] [Related]

  • 10. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF/ICSI.
    Mostinckx L, Goyens E, Mackens S, Roelens C, Boudry L, Uvin V, Segers I, Schoemans C, Drakopoulos P, Blockeel C, De Vos M.
    Hum Reprod; 2024 Mar 01; 39(3):586-594. PubMed ID: 38177084
    [Abstract] [Full Text] [Related]

  • 11. Low ovarian reserve and risk of miscarriage in pregnancies derived from assisted reproductive technology.
    Chinè A, Reschini M, Fornelli G, Basili L, Busnelli A, Viganò P, Muzii L, Somigliana E.
    Hum Reprod Open; 2023 Mar 01; 2023(3):hoad026. PubMed ID: 37287447
    [Abstract] [Full Text] [Related]

  • 12. ESHRE guideline: ovarian stimulation for IVF/ICSI†.
    Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F.
    Hum Reprod Open; 2020 Mar 01; 2020(2):hoaa009. PubMed ID: 32395637
    [Abstract] [Full Text] [Related]

  • 13. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
    Leijdekkers JA, Eijkemans MJC, van Tilborg TC, Oudshoorn SC, McLernon DJ, Bhattacharya S, Mol BWJ, Broekmans FJM, Torrance HL, OPTIMIST group.
    Hum Reprod; 2018 Sep 01; 33(9):1684-1695. PubMed ID: 30085143
    [Abstract] [Full Text] [Related]

  • 14. Significance of serum AMH and antral follicle count discrepancy for the prediction of ovarian stimulation response in Poseidon criteria patients.
    Hochberg A, Dahan MH, Yarali H, Vuong LN, Esteves SC.
    J Assist Reprod Genet; 2024 Mar 01; 41(3):717-726. PubMed ID: 38358433
    [Abstract] [Full Text] [Related]

  • 15. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW, Bentzen JG, Thuesen LL, Lauritsen MP, Forman JL, Loft A, Pinborg A, Nyboe Andersen A.
    Hum Reprod; 2016 May 01; 31(5):1034-45. PubMed ID: 26965431
    [Abstract] [Full Text] [Related]

  • 16. The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.
    Magnusson Å, Nilsson L, Oleröd G, Thurin-Kjellberg A, Bergh C.
    Hum Reprod; 2017 Apr 01; 32(4):811-819. PubMed ID: 28175316
    [Abstract] [Full Text] [Related]

  • 17. A large observational data study supporting the PROsPeR score classification in poor ovarian responders according to live birth outcome.
    Lehert P, Arvis P, Avril C, Massin N, Parinaud J, Porcu G, Rongières C, Sagot P, Wainer R, D'Hooghe T.
    Hum Reprod; 2021 May 17; 36(6):1600-1610. PubMed ID: 33860313
    [Abstract] [Full Text] [Related]

  • 18. Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF.
    Scheinhardt MO, Lerman T, König IR, Griesinger G.
    Hum Reprod; 2018 Aug 01; 33(8):1499-1505. PubMed ID: 30007353
    [Abstract] [Full Text] [Related]

  • 19. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME, Dahhan T, Beerendonk CCM, Fleischer K, Stoop D, Bos AME, Lambalk CB, Schats R, Smeenk JMJ, Louwé LA, Cantineau AEP, de Bruin JP, Linn SC, van der Veen F, van Wely M, Goddijn M.
    Hum Reprod; 2022 Jul 30; 37(8):1786-1794. PubMed ID: 35776109
    [Abstract] [Full Text] [Related]

  • 20. Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study.
    Rutten A, van Ballegooijen H, Broekmans F, Cohlen B, PRORAILS study group.
    Hum Reprod; 2022 Jun 30; 37(7):1440-1450. PubMed ID: 35460412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.